Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy

Journal of Molecular and Cellular Cardiology

Volumn 42, Issue 4, 2007, Pages 884-895

  Hamblin, Milton ^a   Friedman, David B ^b   Hill, Salisha ^b   Caprioli, Richard M ^b   Smith, Holly M ^a   Hill, Michael F ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidants; Cardiomyopathy; Diabetes mellitus; Heart failure; Oxidative stress; Proteomics; Ventricular function

Indexed keywords

GLUTATHIONE; PROSTAGLANDIN F2 ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BIOSYNTHESIS; CARDIOMYOPATHY; CONTROLLED STUDY; DIAGNOSTIC TEST; DOWN REGULATION; GEL ELECTROPHORESIS; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE CONTRACTION; HEART MUSCLE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEMODYNAMICS; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MASS SPECTROMETRY; MITOCHONDRION; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RAT; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; DIABETES MELLITUS, EXPERIMENTAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GLUTATHIONE; MALE; MYOCARDIUM; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEOME; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STREPTOZOCIN;

RATTUS;

EID: 34047111193     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.12.018     Document Type: Article

References (54)

1. Jaffe A.S., Spadaro J.J., Schechtman K., Roberts R., Geltman E.M., and Sobel B.E. Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus. Am. Heart J. 108 (1984) 31-37
2. Bell D.S. Heart failure: the frequent, forgotten, and often fatal complication of diabetes. Diabetes Care 26 (2003) 2433-2441
3. Ye G., Metreveli N.S., Donthi R.V., Xia S., Xu M., Carlson E.C., et al. Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes. Diabetes 53 (2004) 1336-1343
4. Liang Q., Carlson E.C., Donthi R.V., Kralik P.M., Shen X., and Epstein P.N. Overexpression of metallothionein reduces diabetic cardiomyopathy. Diabetes 51 (2002) 174-181
5. Kannel W.B., and McGee D.L. Diabetes and cardiovascular disease. The Framingham study. JAMA 241 (1979) 2035-2038
6. Zarich S.W., and Nesto R.W. Diabetic cardiomyopathy. Am. Heart J. 118 (1989) 1000-1012
7. Mildenberger R.R., Bar-Shlomo B., Druck M.N., Jablonsky G., Morch J.E., Hilton J.D., et al. Clinically unrecognized ventricular dysfunction in young diabetic patients. J. Am. Coll. Cardiol. 4 (1984) 234-238
8. Paillole C., Dahan M., Paycha F., Solal A.C., Passa P., and Gourgon R. Prevalence and significance of left ventricular filling abnormalities determined by Doppler echocardiography in young type I (insulin-dependent) diabetic patients. Am. J. Cardiol. 64 (1989) 1010-1016
9. Bell D.S. Diabetic cardiomyopathy: a unique entity or a complication of coronary artery disease?. Diabetes Care 18 (1995) 708-714
10. Fein F.S., and Sonnenblick E.H. Diabetic cardiomyopathy. Prog. Cardiovasc. Dis. 27 (1985) 255-270
11. Jarrett R.J. Cardiovascular disease and hypertension in diabetes mellitus. Diabetes Metab. Rev. 5 (1989) 547-558
12. Dandona P., Thusu K., Cook S., Snyder B., Makowski J., Armstrong D., et al. Oxidative damage to DNA in diabetes mellitus. Lancet 347 (1996) 444-445
13. Penckofer S., Schwertz D., and Florczak K. Oxidative stress and cardiovascular disease in type 2 diabetes: the role of antioxidants and pro-oxidants. J. Cardiovasc. Nurs. 6 (2002) 68-85
14. Nishio Y., Kashiwagi A., Taki H., Shinozaki K., Maeno Y., Kojima H., et al. Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats. Diabetes 47 (1998) 1318-1325
15. Wohaieb S.A., and Godin D.V. Alterations in tissue antioxidant systems in the spontaneously diabetic (BB Wistar) rat. Can. J. Physiol. Pharmacol. 65 (1987) 2191-2195
16. Wohaieb S.A., and Godin D.V. Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat. Effects of insulin treatment. Diabetes 36 (1987) 1014-1018
17. Palace V., Kumar D., Hill M.F., Khaper N., and Singal P.K. Regional differences in non-enzymatic antioxidants in the heart under control and oxidative stress conditions. J. Mol. Cell Cardiol. 31 (1999) 193-202
18. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature 404 (2000) 787-790
19. Eriksson U.J., and Borg L.A. Diabetes and embryonic malformations. Role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos. Diabetes 42 (1993) 411-419
20. Jain S.K., and Levine S.N. Elevated lipid peroxidation and vitamin E-quinone levels in heart ventricles of streptozotocin-treated diabetic rats. Free Radic. Biol. Med. 18 (1995) 337-341
21. Rajeswari P., Natarajan R., Nadler J.L., Kumar D., and Kalra V.K. Glucose induces lipid peroxidation and inactivation of membrane-associated ion-transport enzymes in human erythrocytes in vivo and in vitro. J. Cell Physiol. 149 (1991) 100-109
22. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 40 (1991) 405-412
23. Gutteridge J.M., and Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem. Sci. 15 (1990) 129-135
24. Mallat Z., Philip I., Lebret M., Chatel D., Maclouf J., and Tedgui A. Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 97 (1998) 1536-1539
25. Morrow J.D., Hill K.E., Burk R.F., Nammour T.M., Badr K.F., and Roberts II L.J. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 9383-9387
26. Delanty N., Reilly M.P., Pratico D., Lawson J.A., McCarthy J.F., Wood A.E., et al. 8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo. Circulation 95 (1997) 2492-2499
27. Wessel D., and Flugge U. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal. Biochem. 138 (1984) 141-143
28. Friedman D.B. Quantitative Proteomics for Two-Dimensional Gels Using Difference Gel Electrophoresis (DIGE). In: Matthiesen R. (Ed). Mass Spectrometry Data Analysis in Proteomics, part of the Methods in Molecular Biology series vol. 367 (2006), The Humana Press Inc. 219-240
29. Alban A., David S.O., Bjorkesten L., Andersson C., Sloge E., Lewis S., et al. A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3 (2003) 36-44
30. Friedman D.B., Hill S., Keller J.W., Merchant N.B., Levy S.E., Coffey R.J., et al. Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 4 (2004) 793-811
31. Kim J.J., and Battaile K.P. Burning fat: the structural basis of fatty acid beta-oxidation. Curr. Opin. Struct. Biol. 12 (2002) 721-728
32. Ahn J.S., Jang I.S., Kim D.I., Cho K.A., Park Y.H., Kim K., et al. Aging-associated increase of gelsolin for apoptosis resistance. Biochem. Biophys. Res. Commun. 312 (2003) 1335-1341
33. Yeo H.C., Helbock H.J., Chyu D.W., and Ames B.N. Assay of malondialdehyde in biological fluids by gas chromatography-mass spectrometry. Anal. Biochem. 220 (1994) 391-396
34. Turko I.V., and Murad F. Quantitative protein profiling in heart mitochondria from diabetic rats. J. Biol. Chem. 278 (2003) 35844-35849
35. Shen X., Zheng S., Thongboonkerd V., Xu M., Pierce Jr. W.M., Klein J.B., et al. Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes. Am. J. Physiol. 287 (2004) E896-E905
36. Ohta S., Ohsawa I., Kamino K., Ando F., and Shimokata H. Mitochondrial ALDH2 deficiency as an oxidative stress. Ann. N. Y. Acad. Sci. 1011 (2004) 36-44
37. Nagahara N., and Katayama A. Post-translational regulation of mercaptopyruvate sulfurtransferase via a low redox potential cysteine-sulfenate in the maintenance of redox homeostasis. J. Biol. Chem. 280 (2005) 34569-34576
38. Sydow K., Daiber A., Oelze M., Chen Z., August M., Wendt M., et al. Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. J. Clin. Invest. 113 (2004) 482-489
39. Martin-Gallan P., Carrascosa A., Gussinye M., and Dominguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic. Biol. Med. 34 (2003) 1563-1574
40. Suzuki Y., Muramatsu T., Taniyama M., Atsumi Y., Kawaguchi R., Higuchi S., et al. Association of aldehyde dehydrogenase with inheritance of NIDDM. Diabetologia 39 (1996) 1115-1118
41. Nandi D.L., Horowitz P.M., and Westley J. Rhodanese as a thioredoxin oxidase. Int. J. Biochem. Cell Biol. 32 (2000) 465-473
42. Williams R.A., Kelly S.M., Mottram J.C., and Coombs G.H. 3-Mercaptopyruvate sulfurtransferase of Leishmania contains an unusual C-terminal extension and is involved in thioredoxin and antioxidant metabolism. J. Biol. Chem. 278 17 (2003) 1480-1486
43. Xu D., Guthrie J.R., Mabry S., Sack T.M., and Truog W.E. Mitochondrial aldehyde dehydrogenase attenuates hyperoxia-induced cell death through activation of ERK/MAPK and PI3K-Akt pathways in lung epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 291 (2006) L966-L975
44. Srivastava S., Chandrasekar B., Bhatnagar A., and Prabhu S.D. Lipid peroxidation-derived aldehydes and oxidative stress in the failing heart: role of aldose reductase. Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H2612-H2619
45. Hartley D.P., and Petersen D.R. Co-metabolism of ethanol, ethanol-derived acetaldehyde, and 4-hydroxynonenal in isolated rat hepatocytes. Alcohol. Clin. Exp. Res. 21 (1997) 298-304
46. Murata C., Taniyama M., Kuriyama S., Muramatsu T., Atsumi Y., Matsuoka K., et al. Meta-analysis of three diabetes population studies: association of inactive ALDH2 genotype with maternal inheritance of diabetes. Diabetes Res. Clin. Pract. 66 Suppl. 1 (2004) S145-S147
47. Esterbauer H., Schaur R.J., and Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11 (1991) 81-128
48. Cai L., Li W., Wang G., Guo L., Jiang Y., and Kang Y.J. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 51 (2002) 1938-1948
49. Fiordaliso F., Li B., Latini R., Sonnenblick E.H., Anversa P., Leri A., et al. Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II-dependent. Lab. Invest. 80 (2000) 513-527
50. Fiordaliso F., Bianchi R., Staszewsky L., Cuccovillo I., Doni M., Laragione T., et al. Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats. J. Mol. Cell Cardiol. 37 (2004) 959-968
51. Yin H.L., and Stossel T.P. Control of cytoplasmic actin gel-sol transformation by gelsolin, a calcium-dependent regulatory protein. Nature 281 (1979) 583-586
52. Ishii T., Iwahashi H., Sugata R., and Kido R. Formation of hydroxanthommatin-derived radical in the oxidation of 3-hydroxykynurenine. Arch. Biochem. Biophys. 294 (1992) 616-622
53. Hiraku Y., Inoue S., Oikawa S., Yamamoto K., Tada S., Nishino K., et al. Metal-mediated oxidative damage to cellular and isolated DNA by certain tryptophan metabolites. Carcinogenesis 16 (1995) 349-356
54. Adolphe A.B., Glasofer E.D., Troetel W.M., Weiss A.J., and Manthei R.W. Preliminary pharmacokinetics of streptozotocin, an antineoplastic antibiotic. J. Clin. Pharmacol. 17 (1977) 379-388